Dr. Battat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1283 York Avenue, 9th Floor
New York, NY 10021
Education & Training
- McGill University Faculty of MedicineClass of 2012
Certifications & Licensure
- NY State Medical License 2019 - 2026
- CA State Medical License 2017 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis Start of enrollment: 2018 Dec 21
Publications & Presentations
PubMed
- 6 citationsIBD Matchmaking: Rational Combination Therapy.Robert Battat, John T Chang, Edward V Loftus Jr, Bruce E Sands
Clinical Gastroenterology and Hepatology. 2025-02-01 - Intensified infliximab induction therapy for steroid-refractory acute severe ulcerative colitis.Diana Coman, Robert Battat
The Lancet. Gastroenterology & Hepatology. 2025-01-01 - 28 citationsECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.Hannah Gordon, Silvia Minozzi, Uri Kopylov, Bram Verstockt, María Chaparro
Journal of Crohn's & Colitis. 2024-10-15
Press Mentions
- Refractory IBD: The Case for Doubling up on DrugsApril 1st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: